Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Dow
Boehringer Ingelheim
Covington
Healthtrust
Queensland Health
Mallinckrodt
Baxter
Cantor Fitzgerald

Generated: April 22, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: pomalidomide

« Back to Dashboard

pomalidomide

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Celgene POMALYST pomalidomide CAPSULE;ORAL 204026 NDA Celgene Corporation N 59572-501-21
Celgene POMALYST pomalidomide CAPSULE;ORAL 204026 NDA Celgene Corporation N 59572-501-00
Celgene POMALYST pomalidomide CAPSULE;ORAL 204026 NDA Celgene Corporation N 59572-502-21
Celgene POMALYST pomalidomide CAPSULE;ORAL 204026 NDA Celgene Corporation N 59572-502-00
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Teva
Moodys
Queensland Health
Daiichi Sankyo
Accenture
Cerilliant
Julphar
Merck